[{"Assets_0_Q2_USD":998235000.0,"CommonStockSharesOutstanding_0_Q2_shares":57932639.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-166395000.0,"NetIncomeLoss_2_Q2_USD":-159570000.0,"NetIncomeLoss_1_Q2_USD":-68745000.0,"StockholdersEquity_0_Q2_USD":823142000.0,"Ticker":"AGIO","CIK":"1439222","name":"AGIOS PHARMACEUTICALS INC","OfficialName":"Agios Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1422760526.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]